Asensus Surgical to Participate in the H.C. Wainwright In-Person BioConnect Investor Conference
RESEARCH TRIANGLE PARK, N.C., April 19, 2023 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the H.C. Wainwright In-Person Bio-Connect Investor Conference. The Company’s fireside chat will take place on Tuesday, May 2, 2023 at 11:30 am Eastern Time.
Related news for (ASXC)
- asensus surgical announces closing of acquisition by karl storz
- Asensus Surgical to Participate in the Oppenheimer 33rd Annual Healthcare Conference
- Asensus Surgical Provides Corporate Update
- Asensus and KARL STORZ to Market the Intelligent Surgical Unit and Co-Develop New Vision and Instrument Platforms